A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

• Status: NOT_YET_RECRUITING
• Trial end date: 2027-07-20

Summary

The purpose of this study is to assess the safety and efficacy of CD19 UCAR-T cell therapy in Subjects with autoimmune diseases.

• Phase: NA

Details

• Lead Sponsor: Institute of Hematology & Blood Diseases Hospital, China